Syner-G Biopharma Group Appoints Ron Kraus as CEO

RESEARCH TRIANGLE PARK, NC: 13 June 2022 Syner-G BioPharma Group (“Syner-G”), a leading provider of consulting services to pharmaceutical and biotechnology clients, today announced that Ron Kraus has joined the company as Chief Executive Officer (CEO). Mr. Kraus has...

IMPACT Celebrates Award from 200th Client

Research Triangle Park, NC—November 15, 2021 – In a virtual gathering, Impact Pharmaceutical Services, Inc. (IMPACT) (now Syner-G BioPharma Group) team members opened boxes specially curated to evoke the trust and mutual respect that has grown out of our relationships...